Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Resonance Health Ltd not to proceed with VueKlar Cardiovascular Ltd acquisition and will focus on existing IP strategy


Thursday, 10 Jul 2014 08:59pm EDT 

Resonance Health Ltd:On June 3, Resonance Health announced it had signed non-binding heads of agreement with VueKlar Cardiovascular Ltd.Purpose was to enable Resonance Health to assess a potential opportunity for the Company.Says it has now completed its due diligence and directors have decided not to proceed further. 

Company Quote

0.05
-0.0040 -7.41%
18 Sep 2014